<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:hpo ids='HP_0000005'>inheritance</z:hpo> of the <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> E4 (APOE4) allele has been shown to increase the plasma cholesterol level, but little information is as concerns the association of the APOE genotype and <z:e sem="disease" ids="C0020473" disease_type="Disease or Syndrome" abbrv="">hyperlipidaemia</z:e> and the activities of two serum enzymes, acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) </plain></SENT>
<SENT sid="1" pm="."><plain>Blood samples from 55 type IIb hyperlipidaemic, non-<z:e sem="disease" ids="C0860630" disease_type="Mental or Behavioral Dysfunction" abbrv="">demented</z:e> patients and 55 age- and sex-matched controls were therefore examined in this pilot study </plain></SENT>
<SENT sid="2" pm="."><plain>A significantly increased BChE activity was found in the serum of type IIb hyperlipidaemic patients, but the AChE activity did not differ significantly as compared with that in the control group </plain></SENT>
<SENT sid="3" pm="."><plain>The APOE4 allele was significantly overrepresented among the hyperlipidaemic probands, but neither serum cholinesterase activity was affected by the dosage of the APOE4 gene </plain></SENT>
<SENT sid="4" pm="."><plain>Our results point to a possible association between an abnormal <z:chebi fb="23" ids="18059">lipid</z:chebi> metabolism and the BChE activity and might have implications as regards the pathomechanism of both Alzheimer's and vascular <z:hpo ids='HP_0000726'>dementias</z:hpo> and the <z:chebi fb="0" ids="37733">cholinesterase inhibitor</z:chebi> therapy of dementing disorders </plain></SENT>
</text></document>